| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
Common |
| Shares
Out: |
22,900,000 |
| Market
Cap: |
34.81(M) |
| Last
Volume: |
145,865 |
Avg
Vol: |
145,470 |
| 52
Week Range: |
$1.17 - $3.61 |
|
| Level
I Sector: |
Information Technology |
| Level
II Sector: |
Computer Hardware |
| Level
III Sector: |
Computer Peripherals |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ COMPUTER |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile iCAD is a medical technology company providing cancer detection and therapy solutions. Co.'s segments are: Cancer Detection, which includes image analysis and workflow solutions that enable healthcare personnel to identify pathologies and pinpoint prevalent cancers earlier, and various Artificial Intelligence and Computer-Aided Detection systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography; and Cancer Therapy, which provides the Xoft Axxent Electronic Brachytherapy System, an isotope-free cancer treatment platform technology for the treatment of early-stage breast cancer, endometrial cancer, cervical cancer and nonmelanoma skin cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
38,960 |
| Total Sell Value |
$0 |
$0 |
$0 |
$106,653 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
1 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ferry Kenneth M |
President, CEO |
• – – |
2014-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
332,600 |
|
- |
|
| Burns Kevin C |
Executive VP, COO, CFO |
• – – |
2014-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
141,839 |
|
- |
|
| Go Jonathan |
Sr. VP of R&D |
• – – |
2014-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
57,000 |
|
- |
|
| Stevens Stacey M |
Sr. VP of Marketing & Strategy |
• – – |
2014-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
77,731 |
|
- |
|
| Subramaniam Somu |
Director |
– • – |
2014-05-09 |
4 |
D |
$0.00 |
$0 |
I/I |
(48,637) |
261,859 |
|
- |
|
| Sussman Elliot J Md Mba |
Director |
– • – |
2014-03-27 |
4 |
OE |
$5.05 |
$24,174 |
D/D |
4,787 |
51,546 |
|
- |
|
| Stevens Stacey M |
Sr. VP of Marketing & Strategy |
• – – |
2014-02-11 |
4/A |
D |
$11.23 |
$30,299 |
D/D |
(2,698) |
57,731 |
|
- |
|
| Stevens Stacey M |
Sr VP of Marketing & Strategy |
• – – |
2014-02-11 |
4/A |
D |
$11.23 |
$30,299 |
D/D |
(2,698) |
59,194 |
|
- |
|
| Stevens Stacey M |
Sr. VP of Marketing & Strategy |
• – – |
2014-02-11 |
4 |
D |
$11.23 |
$34,229 |
D/D |
(3,048) |
58,844 |
|
- |
|
| Ecock Anthony F |
Director |
– • – |
2014-01-17 |
4 |
OE |
$5.05 |
$21,188 |
D/D |
3,000 |
3,000 |
|
- |
|
| Brem Rachel |
Director |
– • – |
2014-01-13 |
4 |
OE |
$5.05 |
$41,496 |
D/D |
7,089 |
7,089 |
|
- |
|
| Howard Dr Lawrence |
Director |
– • – |
2014-01-10 |
4 |
OE |
$5.05 |
$21,188 |
D/D |
3,000 |
450,871 |
|
- |
|
| Sussman Elliot J Md Mba |
Director |
– • – |
2014-01-10 |
4 |
OE |
$6.95 |
$25,805 |
D/D |
3,713 |
46,759 |
|
- |
|
| Rappaport Steven N |
Director |
– • – |
2014-01-09 |
4 |
OE |
$5.05 |
$81,408 |
D/D |
13,648 |
54,060 |
|
- |
|
| Subramaniam Somu |
Director |
– • – |
2013-12-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(60,000) |
310,496 |
|
- |
|
| Burns Kevin C |
Executive VP, CFO and COO |
• – – |
2013-12-12 |
4 |
OE |
$2.27 |
$62,000 |
D/D |
25,000 |
101,839 |
|
- |
|
| Burns Kevin C |
Executive VP of Finance, CFO |
• – – |
2013-05-03 |
4 |
B |
$5.15 |
$15,047 |
D/D |
2,900 |
76,839 |
2.74 |
- |
|
| Stevens Stacey M |
Sr. VP Marketing and Strategy |
• – – |
2013-03-11 |
4 |
D |
$5.49 |
$8,702 |
D/D |
(1,585) |
60,429 |
|
- |
|
| Stevens Stacey M |
Sr. VP of Marketing & Strategy |
• – – |
2013-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
62,014 |
|
- |
|
| Go Jonathan |
Senior VP of R&D |
• – – |
2013-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
47,000 |
|
- |
|
| Ferry Kenneth M |
President, CEO |
• – – |
2013-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
267,600 |
|
- |
|
| Burns Kevin C |
Exec VP Finance, CFO |
• – – |
2013-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
73,939 |
|
- |
|
| Burns Kevin C |
Exeuctive VP of Finance, CFO |
• – – |
2012-08-24 |
4 |
B |
$2.05 |
$31,125 |
D/D |
15,000 |
43,939 |
2.74 |
- |
|
| Burns Kevin C |
Executive VP of Finance, CFO |
• – – |
2012-08-17 |
4 |
B |
$2.89 |
$83,884 |
D/D |
28,939 |
28,939 |
2.74 |
- |
|
| Howard Dr Lawrence |
Director |
– • – |
2012-07-31 |
5 |
GA |
$0.00 |
$0 |
I/I |
92,000 |
75,300 |
|
- |
|
459 Records found
|
|
Page 9 of 19 |
|
|
0.03 (1.94%) 
